Kuros Biosciences AG
Kuros Biosciences AG (SIX: KURN) is trading at CHF 17.93, about ₹2,065 at today's CHF/INR rate, as of 29 Sep 2026, 11:30 AM ET, up 3.94% today. Indian residents can buy Kuros Biosciences from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
CHF 17.23
Today's high
CHF 18.11
52 week low
CHF 16.46
52 week high
CHF 34.20
KURN opened at CHF 17.30, closed previously at CHF 17.25, and has traded between CHF 16.46 and CHF 34.20 over the past 52 weeks.
About
Kuros Biosciences AG functions as a biopharmaceutical enterprise, dedicated to both the development and market introduction of advanced therapeutic solutions for tissue regeneration and bone repair. Its operations span across the United States, the European Union, and other global regions. The company's business activities are structured into three main segments: Medical Devices, Pharmaceuticals, and a Legacy Portfolio. Its orthobiologics product line includes MagnetOs Granules and MagnetOs Putty, available in EU and US markets for various orthopedic, spinal, and dental applications. Within its fibrin/PTH orthobiologics pipeline, KUR-111 has successfully completed a Phase 2b clinical trial for treating tibial plateau fractures. Similarly, KUR-113 has concluded its Phase 2b clinical trial for tibial shaft fractures and is currently undergoing a Phase II trial for spinal interbody fusion procedures. Additionally, Kuros offers sealant products such as Neuroseal, a synthetic tissue sealant marketed in the EU and US, engineered to prevent cerebrospinal fluid leakage after cranial or spinal surgeries. The company also engages in a collaborative endeavor with Checkmate Pharmaceuticals LLC for the advancement of CYT003, intended for oncology treatments. Kuros Biosciences AG is headquartered in Schlieren, Switzerland.
Key statistics
Avg. volume
196.82K
Market cap
CHF 707.15M
P/E Ratio
99.06
Price-to-sales ratio
5.10
Enterprise value
CHF 1.04B
Free cash flow yield
-0.23%
Debt-to-equity ratio
0.15
Return on equity
3.17%
ROIC
4.80%
Beta
0.74
Dividend yield
0.00%
Last dividend
CHF 0.00
Financial overview
Revenue
CHF 121.30M
Earnings per share
CHF 0.06
Free cash flow
-CHF 2.40M
Net profit margin
5.13%
Gross margin
85.28%
EBITDA
CHF 10.13M
Revenue growth
60.54%
Similar securities
This is not an investment recommendation
How to buy Kuros Biosciences from India
Indian residents can buy Kuros Biosciences shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to CHF.
Search for Kuros Biosciences and place an order
Find Kuros Biosciences by name or by its ticker, KURN, and choose an order type. Kuros Biosciences trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Kuros Biosciences position in CHF and INR. Kuros Biosciences pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Kuros Biosciences from India
Trading and taxes when buying Kuros Biosciences from India
Trading and limits
- Trading hours
- 9:00 am – 5:30 pm CET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneKuros Biosciences does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Kuros Biosciences stock?
Yes. Kuros Biosciences (KURN) has been listed on the SIX Swiss Exchange since 2002, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to CHF. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Kuros Biosciences share cost in rupees?
One Kuros Biosciences share is CHF 17.93 — about ₹2,065 at a CHF/INR rate of 115.18 on 29 Sep 2026. Both the Kuros Biosciences price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Kuros Biosciences from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on Kuros Biosciences shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the CHF/INR rate on the purchase and the sale date, so the rupee move counts alongside the Kuros Biosciences price. Paasa issues a capital-gains statement for your return.
Does Kuros Biosciences pay a dividend?
No. Kuros Biosciences does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Kuros Biosciences from India?
The SIX Swiss Exchange trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when Switzerland is on standard time. Orders can only execute during that window.
Do I have to declare Kuros Biosciences shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Kuros Biosciences holding, its cost and its closing value.
How do I sell Kuros Biosciences and bring the money back to India?
You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in CHF in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.
Does the rupee rate affect what I make on Kuros Biosciences?
Yes. Kuros Biosciences is priced in CHF, so your rupee outcome combines the CHF move with the CHF/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.